InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →David Lamond, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 16 open-market SEC Form 4 transactions: 16 purchases worth $812K and 0 sales worth $0, reported from May 20, 22 to Dec 14, 23. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 14, 23 | QNCXQuince Therapeutics, Inc. | BUY | 22.6K | $1.04 | $24K |
| Dec 13, 23 | QNCXQuince Therapeutics, Inc. | BUY | 22.6K | $1.00 | $23K |
| Dec 12, 23 | QNCXQuince Therapeutics, Inc. | BUY | 22.3K | $1.02 | $23K |
| Dec 7, 23 | QNCXQuince Therapeutics, Inc. | BUY | 19.1K | $1.01 | $19K |
| Dec 6, 23 | QNCXQuince Therapeutics, Inc. | BUY | 19.1K | $1.02 | $20K |
| Dec 5, 23 | QNCXQuince Therapeutics, Inc. | BUY | 19.1K | $1.01 | $19K |
| Dec 1, 23 | QNCXQuince Therapeutics, Inc. | BUY | 14.4K | $0.94 | $14K |
| Nov 30, 23 | QNCXQuince Therapeutics, Inc. | BUY | 14.4K | $0.90 | $13K |
| Nov 29, 23 | QNCXQuince Therapeutics, Inc. | BUY | 14.4K | $0.98 | $14K |
| Aug 31, 23 | QNCXQuince Therapeutics, Inc. | BUY | 41.0K | $1.32 | $54K |
| Aug 30, 23 | QNCXQuince Therapeutics, Inc. | BUY | 41.0K | $1.31 | $54K |
| Aug 17, 23 | QNCXQuince Therapeutics, Inc. | BUY | 24.8K | $1.29 | $32K |
| Aug 16, 23 | QNCXQuince Therapeutics, Inc. | BUY | 117.3K | $1.29 | $151K |
| Aug 15, 23 | QNCXQuince Therapeutics, Inc. | BUY | 107.9K | $1.32 | $142K |
| May 23, 22 | AMTIApplied Molecular Transport Inc. | BUY | 33.5K | $3.26 | $109K |
| May 20, 22 | AMTIApplied Molecular Transport Inc. | BUY | 33.0K | $3.08 | $102K |